Innovation Pharmaceuticals Inc (IPIX)

[ICEVRE3]

Thanks for the chuckle.

I also got a kick out of steelyeye's
"European Stereotypes."

Forgive me if this is slightly off topic or has already been discussed. I was reviewing Trovagene's recent 8/10K and a couple of things in the notes looked familiar. I was wondering if there was any correlation?

Can their urine test be used to detect mutations in the gene, that Kevetrin could then help correct in certain patients? Sounds like a good diagnostic/treatment partnership opportunity.




Review of 2012 and 2013 Announcements Demonstrate Progress in Development Programs

* Launched HPV-HR assay, a urine-base molecular human papillomavirus (HPV) test
in 2013.
* Extended planned offering of urine-based oncogene mutation tests to include a
test for the detection of a specific p53 mutation and a specific double
mutation in the hepatitis B virus in 2013.
* Expanded clinical collaboration with the University of Texas MD Anderson
Cancer Center to include the detection of transrenal BRAF mutations in the
urine of patients with advanced or metastatic cancers in 2013 from an initial
collaboration for the detection transrenal KRAS mutation in the urine of
patients with pancreatic cancer in 2012.
* Entered into research collaboration with Brazil's Barretos Cancer Hospital to
evaluate Trovagene's urine-based HPV assay as a potential Pap smear replacement
in 2012.
* Entered into an agreement with India's Strand Life Sciences to validate and
commercialize the HPV assay in India and South Asia in 2012.
* Granted licenses for NPM1 marker for acute myelogenous leukemia to Quest
Diagnostics, Duke University and Genoptix, Inc. in 2012. Received a milestone
payment related to the NPM1 patent issuance from Ipsogen, S.A.
* Strengthened patent portfolio. Received notification of issuance of two U.S.
patents in 2012. Trovagene now has 60 issued patents and 47 pending patents.
* Acquired a CLIA-certified, CAP-approved laboratory in 2012.

http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001104659-13-026267%2Etxt&FilePath=%5C2013%5C04%5C02%5C&CoName=TROVAGENE%2C+INC%2E&FormType=8-K&RcvdDate=4%2F2%2F2013&pdf=

Exhibit 99.1